Reimagining skin diagnostics with hyperspectral imaging—
compact, powerful, and built for the future of clinical care.
Bringing hyperspectral imaging out of the lab and into the clinic with a novel, low-cost system spanning 400–1700 nm.
By integrating DMD-based scanning and custom optics, our compact design delivers high-resolution spectral data making advanced skin
diagnostics accessible, scalable, and ready for real-world healthcare applications.
Our Purpose
Our project, supported by Aly Development, aims to tackle a significant unmet need: creating a low-cost, accessible, and non-invasive way to diagnose allergies.
Current methods are stressful for patients, expensive, and most often inaccessible to low-income communities. Access to allergists and allergy testing also remains limited for underserved populations—both in the U.S. and globally.
Portable
Designed for real-world use, our compact hyperspectral system fits comfortably into clinical environments. Its simple form factor removes the need for large lab setups, enabling easier point-of-care imaging.
Non-Invasive
Traditional allergy testing is generally invasive and uncomfortable for patients. To minimize this, we avoid invasive techniques, directly promoting user-friendly practice and safety.
Low-cost
Through smart engineering, we’ve created a powerful imaging tool that dramatically lowers the cost of hyperspectral diagnostics. It’s built to make cutting-edge technology accessible to more clinics and communities.
Learn more about the problem and our soultion
Allergy tests typically cost between $100 and $300, and patients often face wait times ranging from a few weeks to a few months just for results.
Current tests—like skin pricks and patch testing—involve applying allergens directly to the skin or injecting them just below the surface, which can be uncomfortable and even painful. Blood tests are also invasive and come with their own costs and delays.
On top of that, the number of allergists available is alarmingly low. Globally, there’s only about one allergist for every 25 million people, making it incredibly difficult for marginalized communities to get the care they need.
There is currently no widely accepted standard for testing across different skin tones, which can make accurate diagnosis even more challenging and prolong wait times.
With around 22% of the global population in need of allergy diagnostics, there’s a clear demand for more patient-friendly and widely accessible alternatives. Motivated by these issues, we’re focused on creating a more comfortable and accessible experience for allergy testing. Our goal is to remove both the cost and discomfort associated with traditional allergy tests while also addressing the shortage of allergists in many parts of the world. We’re doing this by building a low-cost, portable, and non-invasive version of a hyperspectral imaging system that can deliver fast and reliable allergy diagnostics.
Learn more about our device by clicking below!